Sudden discontinuation of fluvoxamine maleate tablets may result in irritability, agitation, dizziness, etc. Gradual reduction of the dose and monitoring of the patient’s performance are required as prescribed by the physician. Discontinuation and especially abrupt discontinuation of fluvoxamine maleate tablets may be associated with adverse events such as insomnia, hypomania, mood lability, lethargy, headache, confusion, anxiety, sensory disorders, dizziness, agitation, irritability, and irritability of mind, which are generally self-limiting, although serious cases have been reported. When discontinuing this product, patients should be monitored for any of the above symptoms, and it is recommended that the dosage be gradually reduced rather than abruptly discontinued. If the dosage is reduced or the patient becomes intolerant when discontinuing the product, consider temporarily resuming the original prescribed dosage first, and then reducing the dosage at a slower rate. It is recommended that patients go to a regular hospital for consultation if they feel unwell, and follow the doctor’s instructions to use or stop the medication, rather than stopping the medication on their own.